|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/5585 | |
| A61P 9/00 |
| (11) | Patento numeris | 2879684 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13824807.5 |
| Europos patento paraiškos padavimo data | 2013-07-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-06-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-01-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/052700 |
| Data | 2013-07-30 |
| (87) | Numeris | WO 2014/022376 |
| Data | 2014-02-06 |
| (30) | Numeris | Data | Šalis |
| 201261678208 P | 2012-08-01 | US | |
| 201361750458 P | 2013-01-09 | US |
| (72) |
JEFFS, Roger, US
PETERSEN, Thomas, US
ILAGAN, Roger M., US
WADE, Michael, US
|
| (73) |
United Therapeutics Corporation,
1040 Spring Street, Silver Spring, MD 20910,
US
|
| (54) | TREATMENT OF PULMONARY ARTERIAL HYPERTENSION WITH PROSTACYCLIN-TREATED ENDOTHELIAL PROGENITOR CELLS |
| TREATMENT OF PULMONARY ARTERIAL HYPERTENSION WITH PROSTACYCLIN-TREATED ENDOTHELIAL PROGENITOR CELLS |